This activity is expired and is no longer available for CME credit.


Nitric Oxide in Glaucoma: What You Need to Know

Author(s)/Faculty: John P. Berdahl, MD; John R. Samples, MD; Thomas W. Samuelson, MD
Release Date: 2/11/2020Expiration Date: 2/10/2021
Credit Type: CMENumber of Credits: 0
Content Type: LectureProvider:
Glaucoma continues to be a leading cause of blindness worldwide with many patients at risk for disease progression due to inadequate control of intraocular pressure (IOP). Evaluation of nitric oxide signaling has demonstrated that it plays a key role in IOP regulation via its action on the conventional outflow pathway. These findings have led to the development of nitric oxide–donating agents that have the potential to produce significant improvements in IOP control. In this live educational symposium, experts in the field will review the role of the nitric oxide pathway in the regulation of IOP, as well as evaluate new evidence regarding the safety and efficacy of nitric oxide–based therapies for the treatment of patients with glaucoma.